We allow biopharma to ask the right people the right questions at the right time

Because market access strategies should be rooted in the truth, not conjecture.

Formulary Insights helps biopharma manufacturers and investors navigate the US market access landscape

Clients leverage the combined expertise of our team and our panel of advisors to maximize their return on investment whether BD&L, pipeline development or inline product performance.

At Formulary Insights, all our panelists are active decision makers

No retirees. No loose affiliations. No misrepresentations.

Click below for a brief description of the value Formulary Insights can bring to your organization.

LATEST ARTICLES

CONTACT US

There is finally a better way.

Get REAL insights from ACTIVE market access decision makers in time to act.
 
Our market access experts are ready to go to work for you today.

HOW WE ARE BETTER

Will your clinical trials deliver the leverage you need with payers?

The quality of the clinical evidence will forever be the cornerstone of every payer engagement. Poor integration of payer insights into...

Exclusive Agreement with the National Association of Specialty Pharmacy (NASP)

Formulary Insights transformed the payer market research landscape providing a better way to capture and deliver accurate payer insights.

3 Reasons US Payers Will Make 2021 a Banner Year for Biosimilars

Following a year which saw a 143% increase in launched biosimilars in the US, three reasons why payers will drive adoption further in 2021.

A Better Path to Payer Insights

Payers have transformed the competitive marketplace, and biopharma companies need to regain their role as the authority on their products.

OUR PEOPLE

Experienced market access experts at your side from start-to-finish

OUR PANEL

Only active market access decision makers… no retirees, no loose affiliations

OUR APPROACH

Agile research unleashes progressive learning and more actionable insights